Companies/US/JSPR

JASPER THERAPEUTICS, INC.

Ownership & governance

Executives 5Directors 7Avg age 59Avg tenure 3.1y
Jeet Mahal
Chief Executive Officer
Age 54Since 2026-01-05Profile →

Shareholders5

NameStakeShares
Velan Capital Investment Management LP
9.531 %
2,668,395
Millennium Management LLC
5.778 %
1,617,531
Acorn Capital Advisors LLC
5.042 %
1,411,492
Kingdon Capital Management LLC
4.829 %
1,352,106
Morgan Stanley Capital Services LLC
4.763 %
1,333,420

Catalog · 2026-07-09

SEC officers12

NameRoleSinceShares
Daniel AdelmanChief Tech/Sci/R&D Officer2023-03-22-
Herbert CrossDirector of Finance/CFO2023-09-21-
Luca Di NotoChief Tech/Sci/R&D Officer2019-12-31-
Thomas WiggansChairman2023-10-31-
Jeet MahalDirector/Board Member2026-01-05-
Judith ShizuruDirector/Board Member2021-09-03-
Kurt von EmsterDirector/Board Member2021-09-23-
Scott BrunDirector/Board Member2023-06-19-

SEC · as of 2026-09-28

Institutional (13F)

Loading Form 13F holders…

Fund membership

Loading fund baskets…

Street consensus

Consensus noneMean target 20Range 20–20Analysts 1
  • Buy 1

Broker actions40 of 46

FirmActionToTargetDate
Piper SandlerInitiatedOverweight22026-08-12
TD CowenDowngradeHold—2026-05-15
RBC CapitalMaintainedSector Perform32026-05-15
Evercore ISI GroupMaintainedOutperform72026-04-01
RBC CapitalMaintainedSector Perform42025-11-11
Evercore ISI GroupMaintainedOutperform142025-09-22
JMP SecuritiesMaintainedMarket Outperform62025-09-22
BTIGMaintainedBuy72025-09-22
UBSMaintainedBuy252025-08-15
BMO CapitalDowngradeMarket Perform42025-07-08
JMP SecuritiesMaintainedMarket Outperform122025-07-08
Evercore ISI GroupMaintainedOutperform202025-07-08

Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.

Peers